Cancer Diagnostics Market 2018 – Regional Overview | Absolute Analysis | Industry Key Factors Top Competitors by 2023

“Market Research Future”
The report on Global Cancer Diagnostics Market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report broadly provides the market Growth, trends and forecasts for the period 2018–2023.

Cancer is the uncontrolled growth of tumor cells anywhere in the body and can spread to the other parts of body. There are more than 200 different types of cancer such as breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and many more. Several methods, advance technology, have surfaced for diagnosing cancer at an early stage. The continuously rising number of patients suffering with different type of cancer is majorly leading the cancer diagnostics market.

Cancer Diagnostics Market is expected to grow at a CAGR of 11.8% during the forecast period 2017-2023. Some of key the players in the market are Armune BioScience, Inc. (U.S.), Arquer Diagnostics Ltd (U.K), BioMark Diagnostics Inc. (Canada), Biotheranostics, Inc. (U.S.), Cancer Diagnostics, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K), QIAGEN N.V.  (Netherlands), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Philips Healthcare (U.K.), C.R. Bard, Inc. (U.S.).

Market Scenario:

According to the WHO, cancer was the leading cause of the total number of deaths globally as of 2015 and was responsible for 8.8 million deaths. The most common causal agents identified are cigarettes, cigars, pipes and chewing tobacco. According to a study done by Cancer Research U.K, looking at the lifestyle factors responsible, it has been found that out of 3 diagnosed cases, 1 may be linked to smoking.

Access Sample Copy @ .

According to National Instituted of Health (NIH) it has been found that as of 2016, a projected 1,685,210 new cases of cancer were reported in the United States and 595,690 individuals died from the disease which further increases the urgency and thereby the growth of the market.

Most of the cancer are hard to catch, even if we are aware of the symptoms to search for. This leads to a late diagnosis and makes the treatment more difficult. Thus, companies are more into merger and acquisition activity in order to introduce better diagnosis procedure. In this regards, Progenics Pharmaceuticals, Inc., 2015, acquired Exini Diagnostics AB in order to support its imaging and therapeutic agents with sophisticated analytical tools and other technologies to help patients and physicians understand, target and treat one of the most common cancers in the male population –prostate cancer.

Table of Content:

1. Report Prologue

2. Market Introduction

3. Research Methodology

4. Market Dynamics

5. Market Factor Analysis

6. Global Cancer Diagnostics Market, By Type

7. Global Cancer Diagnostics Market, By Application

8. Global Cancer Diagnostics Market, By End User

9. Global Cancer Diagnostics Market, By Region


For more Information visit @ .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India